BVF Partners, Director: Kymera Therapeutics KYMR Sell · Filed 06/26

Trade details

Type: Insider sale
Amount: $89,237,841
Shares · price: 837,914 sh · $106.50 a share
Held after: 1,960,881 sh
Stock: Kymera Therapeutics KYMR
Person: BVF PartnersDirector
Trade date: 26/06/26
Filed: 26/06/26
Days to filing: 0 days

Sold 29.9% of holdings

Share of holding sold: 29.9%

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 05/27~07/26

BVF Partners's recent trades

BVF PartnersDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$66.8M
627,597 sh
$66.8M
Filed 06/26
Traded 06/26
BVF PartnersDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$12.1M
113,289 sh
$12.1M
Filed 06/26
Traded 06/26
BVF PartnersDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$5.5M
51,858 sh
$5.5M
Filed 06/26
Traded 06/26
BVF PartnersSEE REMARKS and Footnotes
Planned saleKymera Therapeutics
Planned sale
Kymera Therapeutics
KYMR
$189.9M
1,630,658 sh
$189.9M
Filed 06/26
Traded 06/26
BVF PartnersDirector
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$32.4M
1,932,354 sh
$32.4M
Filed 04/02
Traded 03/31